These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10808252)
1. How BCG led to the discovery of immunostimulatory DNA. Tokunaga T; Yamamoto T; Yamamoto S Jpn J Infect Dis; 1999 Feb; 52(1):1-11. PubMed ID: 10808252 [TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA. Lee KW; Jung J; Lee Y; Kim TY; Choi SY; Park J; Kim DS; Kwon HJ Mol Immunol; 2006 May; 43(13):2107-18. PubMed ID: 16442622 [TBL] [Abstract][Full Text] [Related]
5. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development. Yamamoto S; Yamamoto T; Nojima Y; Umemori K; Phalen S; McMurray DN; Kuramoto E; Iho S; Takauji R; Sato Y; Yamada T; Ohara N; Matsumoto S; Goto Y; Matsuo K; Tokunaga T Jpn J Infect Dis; 2002 Apr; 55(2):37-44. PubMed ID: 12082305 [TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs? Verfaillie T; Cox E; Goddeeris BM Vet Immunol Immunopathol; 2005 Jan; 103(1-2):141-51. PubMed ID: 15626469 [TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Zelenay S; Elías F; Fló J Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065 [TBL] [Abstract][Full Text] [Related]
9. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. Weiner GJ J Leukoc Biol; 2000 Oct; 68(4):455-63. PubMed ID: 11037965 [TBL] [Abstract][Full Text] [Related]
10. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy. Chaung HC Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831 [TBL] [Abstract][Full Text] [Related]
11. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside. O'Malley BW; Li D; McQuone SJ; Ralston R Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147 [TBL] [Abstract][Full Text] [Related]
12. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model. Bertin S; Anjuere F; Gavelli A; Baque P; Soilihi BK; Brossette N; Loubat A; Pierrefite-Carle V Int J Mol Med; 2008 Mar; 21(3):309-15. PubMed ID: 18288378 [TBL] [Abstract][Full Text] [Related]
13. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro. Wattrang E; Berg M; Magnusson M Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566 [TBL] [Abstract][Full Text] [Related]
16. Antitumor vaccination: where we stand. Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658 [TBL] [Abstract][Full Text] [Related]
17. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity. Rattanakiat S; Nishikawa M; Funabashi H; Luo D; Takakura Y Biomaterials; 2009 Oct; 30(29):5701-6. PubMed ID: 19604576 [TBL] [Abstract][Full Text] [Related]
18. [Augmentation of the immunostimulatory effects of plasmid DNA by incorporation of human CpG-oligodeoxynucletide]. Xu H; Deng Y; Wang S; Guo F; Lu R; Ruan L Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):492-5. PubMed ID: 12133524 [TBL] [Abstract][Full Text] [Related]
19. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Yew NS; Zhao H; Wu IH; Song A; Tousignant JD; Przybylska M; Cheng SH Mol Ther; 2000 Mar; 1(3):255-62. PubMed ID: 10933941 [TBL] [Abstract][Full Text] [Related]
20. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN. de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]